Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

159
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159
Bioreactor Design and Operational System01:29

Bioreactor Design and Operational System

200
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
200
Designing Growth Media for Bioreactors01:30

Designing Growth Media for Bioreactors

78
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
78
Scale-Up Processes01:14

Scale-Up Processes

105
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
105
Upstream Processing01:27

Upstream Processing

97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Edible Coatings for Ready-to-Eat Products: Critical Review of Recent Studies, Sustainable Packaging Perspectives, Challenges and Emerging Trends.

Polymers·2025
Same author

Enhanced production of N-acetyl-glucosaminidase by marine Aeromonas caviae CHZ306 in bioreactor.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2023
Same author

Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles.

Frontiers in bioengineering and biotechnology·2019
Same author

Evaluation of center-cut separations applying simulated moving bed chromatography with 8 zones.

Journal of chromatography. A·2016
Same journal

Engineering gut microbiota-derived enzymes for glycosaminoglycan metabolism: Catalytic mechanisms, diversity, and technologies.

Biotechnology advances·2026
Same journal

Computational advances in epigenetic regulation databases and prediction tools.

Biotechnology advances·2026
Same journal

DNA mini-barcoding: An innovative solution for degraded DNA and its multidisciplinary application landscape.

Biotechnology advances·2026
Same journal

Biosensors with enzymatic amplification strategies for the detection of foodborne pathogenic microorganisms.

Biotechnology advances·2026
Same journal

Cell surface display for nutritional chemicals: Strategies, mechanisms, and evaluation methods.

Biotechnology advances·2026
Same journal

Advancing synthetic biology with engineered chemically inducible gene regulatory systems.

Biotechnology advances·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.0K

A roadmap for model-based bioprocess development.

Khadija Mu'azzam1, Francisco Vitor Santos da Silva2, Jason Murtagh3

  • 1Process & Chemical Engineering, School of Engineering & Architecture, University College Cork, Ireland; DPS Group Cork, Arcadis, Netherlands.

Biotechnology Advances
|May 16, 2024
PubMed
Summary
This summary is machine-generated.

The biopharmaceutical industry is shifting to Quality by Design (QbD) for better product consistency and efficiency. Industry 4.0/5.0 technologies like Digital Twins are key to implementing QbD, despite facing integration challenges.

Keywords:
Biopharmaceutical manufacturingDesign spaceDigital twinsIndustry 4.0Industry 5.0Process modellingProcess simulationQuality by design

More Related Videos

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.4K
Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.6K

Related Experiment Videos

Last Updated: May 5, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.0K
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.4K
Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.6K

Area of Science:

  • Biopharmaceutical Process Development
  • Quality Assurance in Biologics Manufacturing
  • Industrial Biotechnology

Background:

  • The biopharmaceutical industry is transitioning from Quality by Testing (QbT) to a more proactive Quality by Design (QbD) approach.
  • QbD integrates quality into process development, aiming for enhanced operational efficiencies and reduced time-to-market.
  • Regulatory frameworks guide QbD implementation through defined elements like Quality Target Product Profiles (QTPPs) and Critical Quality Attributes (CQAs).

Purpose of the Study:

  • To critically analyze the key elements of Quality by Design (QbD) implementation in bioprocessing.
  • To examine the transformative role of Industry 4.0 and 5.0 technologies in advancing QbD.
  • To review the development and application of models within Digital Twins (DTs) for bioprocessing optimization.

Main Methods:

  • Critical analysis of QbD principles and their constituent elements (QTPPs, CQAs, Design Spaces, Control Strategies).
  • Review of Industry 4.0/5.0 technologies (AI, ML, IoT, DTs) and their impact on bioprocessing.
  • Exploration of modeling approaches (mechanistic, empirical, hybrid) and advanced data collection technologies for DTs.

Main Results:

  • QbD implementation relies on defining QTPPs, CQAs, Design Spaces, and Control Strategies for consistent product quality and compliance.
  • Industry 4.0/5.0 technologies, particularly Digital Twins (DTs), enable real-time data analysis, predictive modeling, and process optimization.
  • DTs face challenges in system integration and data security, being addressed by AI and advanced communication technologies.

Conclusions:

  • The integration of advanced technologies like Digital Twins is crucial for effective QbD implementation in bioprocessing.
  • Model development and advanced data collection are vital for the accuracy and predictive power of Digital Twins.
  • Continued advancements in technology and modeling are essential for optimizing bioprocessing and ensuring product quality.